Drug Treatment in Rheumatoid Arthritis

Introduction: Rheumatoid arthritis is the most common inflammatory autoimmune rheumatic disease that without proper treatment can cause permanent lesions and deformities of the joints resulting in long-term functional disability or disability. Purpose: In this review study is provided the pharmaceutical treatment of rheumatoid arthritis in order to promote the quality of life of these patients. Material amp Methods: The material of the study was a recent article on the topic found mainly in the Medline database and the Hellenic Academic Libraries Association (HEAL-Link). Results: Early diagnosis of the disease, as well as early onset of treatment, helps significantly in the successful management of the disease. Conventional treatment for rheumatoid arthritis includes non-steroidal anti-inflammatory anti-rheumatic drugs or other disease-modifying drugs such as methotrexate and corticosteroids. The goal of medication is to reduce pain and inflammation, minimize loss of function, and prevent complications and joint damage. Conclusions: The goal of pharmaceutical therapy is the recession of inflammation. Treatment planning is also different for each patient both because the disease is not as severe in everyone as the needs of each patient are different.